Xenotransplantation under the Food and Drug Administration’s Expanded Access pathway

Christopher Bobier; Daniel Rodger

doi:10.1016/j.ajt.2024.05.015

Xenotransplantation under the Food and Drug Administration’s Expanded Access pathway

Christopher Bobier, Daniel Rodger

Radiography & Operating Department Practice

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Abstract

No abstract provided

Original language	English
Pages (from-to)	1911-1912
Number of pages	2
Journal	American Journal of Transplantation
Volume	24
Issue number	10
Early online date	22 May 2024
DOIs	https://doi.org/10.1016/j.ajt.2024.05.015
Publication status	E-pub ahead of print - 22 May 2024

Bibliographical note

The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. Daniel J. Hurst is a paid consultant with a xenotransplant research group at New York University. Christopher Bobier and Daniel Rodger declare no conflict of interest.

Keywords

Xenotransplantation
transplantation
compassionate use
zoonosis

Access to Document

10.1016/j.ajt.2024.05.015

Xenotransplantation under the FDA s Expanded Access Pathway - Accepted version

Cite this

@article{e52e1a37a7fe4c30a802665c7966e8eb,

title = "Xenotransplantation under the Food and Drug Administration{\textquoteright}s Expanded Access pathway",

abstract = "No abstract provided",

keywords = "Xenotransplantation, transplantation, compassionate use, zoonosis",

author = "Christopher Bobier and Daniel Rodger",

note = "The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. Daniel J. Hurst is a paid consultant with a xenotransplant research group at New York University. Christopher Bobier and Daniel Rodger declare no conflict of interest.",

year = "2024",

month = may,

day = "22",

doi = "10.1016/j.ajt.2024.05.015",

language = "English",

volume = "24",

pages = "1911--1912",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Elsevier B.V.",

number = "10",

}

TY - JOUR

T1 - Xenotransplantation under the Food and Drug Administration’s Expanded Access pathway

AU - Bobier, Christopher

AU - Rodger, Daniel

N1 - The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. Daniel J. Hurst is a paid consultant with a xenotransplant research group at New York University. Christopher Bobier and Daniel Rodger declare no conflict of interest.

PY - 2024/5/22

Y1 - 2024/5/22

N2 - No abstract provided

AB - No abstract provided

KW - Xenotransplantation

KW - transplantation

KW - compassionate use

KW - zoonosis

U2 - 10.1016/j.ajt.2024.05.015

DO - 10.1016/j.ajt.2024.05.015

M3 - Letter

SN - 1600-6135

VL - 24

SP - 1911

EP - 1912

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 10

ER -